Catalyst Pharmaceuticals (CPRX) Treasury Shares (2014 - 2026)
Catalyst Pharmaceuticals posted quarterly Treasury Shares of $615765.0 for Q1 2026, down 18.18% on a QoQ basis from $752626.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 10 years of Treasury Shares data on file, last reported at $615765.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares changed N/A year-over-year to $615765.0; the trailing twelve-month figure through Mar 2026 stood at $615765.0 (changed N/A YoY), and the FY2025 full-year result was $752626.0, up 6.16% from the prior year.
- Treasury Shares for Q1 2026 stood at $615765.0, down from $752626.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.0 million in Q4 2022 and bottomed at -$1.0 million in Q3 2022.
- The 4-year median for Treasury Shares is $615765.0 (2026), against an average of $153907.3.
- Peak annual rise in Treasury Shares reached 145.28% in 2022, while the deepest fall reached 697.01% in 2022.
- A 4-year view of Treasury Shares shows it stood at $1.0 million in 2022, then decreased by 29.1% to $708960.0 in 2024, then gained by 6.16% to $752626.0 in 2025, then slipped by 18.18% to $615765.0 in 2026.
- The last three Treasury Shares figures came in at $615765.0 (Q1 2026), $752626.0 (Q4 2025), and $708960.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 615,765.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 615,765.00 |
| Mar 31, 2026 | 615,765.00 |
| Dec 31, 2025 | 752,626.00 |
| Dec 31, 2025 | 752,626.00 |
| Dec 31, 2024 | 708,960.00 |
| Dec 31, 2024 | 708,960.00 |
| Dec 31, 2022 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Jun 30, 2022 | -600,000.00 |
| Jun 30, 2022 | -600,000.00 |
| Mar 31, 2022 | -400,000.00 |
| Mar 31, 2022 | -400,000.00 |
| Dec 31, 2021 | -2.21 Mn |
| Dec 31, 2021 | -2.21 Mn |
| Sep 30, 2021 | 950,000.00 |
| Sep 30, 2021 | 950,000.00 |
| Jun 30, 2021 | 733,000.00 |
| Jun 30, 2021 | 733,000.00 |
| Mar 31, 2021 | 67,000.00 |
| Mar 31, 2021 | 67,000.00 |
| Dec 31, 2020 | 235,671.00 |
| Dec 31, 2020 | 235,671.00 |
| Dec 31, 2019 | 352,500.00 |
| Dec 31, 2019 | 352,500.00 |
| Dec 31, 2016 | 26,667.00 |
| Dec 31, 2016 | 26,667.00 |
| Dec 31, 2015 | 53,334.00 |
| Dec 31, 2015 | 53,334.00 |
| Dec 31, 2014 | 80,000.00 |
| Dec 31, 2014 | 80,000.00 |